Refine by
Anti Inflammatory Equipment Supplied In Australia
10 equipment items found
Manufactured by:Sigma-Aldrich based inBellefonte, PENNSYLVANIA (USA)
Developed and optimized for the extraction of non-steroidal anti-inflammatory drugs (NSAIDs) from aqueous samples such as drinking and waste water. The NSAIDs that we have tested so far include: Naproxen, Clofibric Acid, Diclofenac, and Ibuprofen. The SupelMIP SPE - NSAIDs phase is compatible with other non-carboxylic acid ...
Manufactured by:Botanix Pharmaceuticals based inNorth Perth, AUSTRALIA
Synthetic CBD has been shown in scientific studies to normalise excessive lipid synthesis of human sebocytes, suppress cell proliferation, and provide an anti-inflammatory effect potentially reduce bacterial infection. In turn, this could help to reduce the occurrence or severity of serious acne. ...
Manufactured by:Botanix Pharmaceuticals based inNorth Perth, AUSTRALIA
BTX1702 is a new product opportunity for the treatment of papulopustular rosacea. Rosacea is a chronic inflammatory skin disease that often begins with a tendency to blush or flush more easily than other people, but can progress into many subtypes, including papulopustular rosacea. Papulopustular rosacea is a highly visible and distressing chronic ...
Manufactured by:Enagic - Kangen Water based inTorrance, CALIFORNIA (USA)
It has been known since the era of the Ryukyu Dynasty as a strong antioxidant, and India's ancient medicine (Ayurveda) has used turmeric as an analgesic, antibacterial, anti-inflammatory, anti-allergic, and antioxidant for over 6,000 ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
Remestemcel-L is being developed for inflammatory diseases in children and adults including the treatment of acute graft versus host disease (aGVHD), a potentially life-threatening complication of an allogeneic bone marrow transplant (BMT). Currently, there are no products currently approved in the United States for treatment of steroid-refractory aGVHD in children under 12, and off-label options ...
Manufactured by:Regeneus Ltd. based inPaddington, AUSTRALIA
Progenza is a cryopreserved multi-synergistic therapy targeting pain and inflammation. Regeneus has patented techniques and high-quality testing to ensure the production of millions of Progenza™ doses from a single donor (allogeneic). ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-25-Osteo for spinal fusion is a proprietary Phase 3-ready product candidate. All doses of MPC-25-Osteo for the treatment of spinal fusion consist of 25 million MPCs delivered on a collagen ceramic carrier material into the disc space with stabilizing ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-06-ID is a Phase 3 product candidate for the treatment of chronic low back pain caused by disc degeneration (CLBP). It is being developed for patients who have exhausted conservative treatment options, may have failed epidural steroid injections and have no further treatment option other than invasive and costly surgical ...
by:AdAlta Limited based inBundoora, AUSTRALIA
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, CXCR4 and demonstrates anti-fibrotic effects in several models of fibrosis. This was initially called AD-114. Following further development, AdAlta ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-300-IV is being developed for the treatment of diabetic complications, including diabetic kidney disease known as diabetic ...